p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease | Zendy

Björn Meijers | Zendy; Kathleen Claes | Zendy; Bert Bammens | Zendy; Henriëtte de Loor | Zendy; Liesbeth Viaene | Zendy; Kristin Verbeke | Zendy; Dirk Kuypers | Zendy; Yves Vanrenterghem | Zendy; Pieter Evenepoel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease

Author(s) -

Björn Meijers,

Kathleen Claes,

Bert Bammens,

Henriëtte de Loor,

Liesbeth Viaene,

Kristin Verbeke,

Dirk Kuypers,

Yves Vanrenterghem,

Pieter Evenepoel

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07971109

Subject(s) - medicine , renal function , kidney disease , hazard ratio , risk factor , univariate analysis , disease , dialysis , cardiology , endocrinology , multivariate analysis , confidence interval

Cardiovascular disease is highly prevalent in chronic kidney disease. Traditional risk factors are insufficient to explain the high cardiovascular disease prevalence. Free p-cresol serum concentrations, mainly circulating as its derivative p-cresyl sulfate, are associated with cardiovascular disease in hemodialysis patients. It is not known if p-cresol is associated with cardiovascular disease in patients with chronic kidney disease not yet on dialysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research